Skip to main content

Pulmozyme Prices, Coupons, Copay Cards & Patient Assistance

Pulmozyme (dornase alfa) is a member of the miscellaneous respiratory agents drug class and is commonly used for Cystic Fibrosis.

The cost for Pulmozyme (2.5 mg/2.5 mL) inhalation solution is around $4,294 for a supply of 75 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Pulmozyme prices

Inhalation Solution

2.5 mg/2.5 mL

Pulmozyme inhalation solution

 from $4,294.22

for 75 milliliters
Quantity Per unit Price
75 (30 x 2.5 milliliters) $57.26 $4,294.22

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Pulmozyme Coupons, Copay Cards and Rebates

Pulmozyme offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Pulmozyme Co-Pay Card Program

Eligible commercially insured patients pay as little as $30 per 30-day supply with savings of up to $10,000 per calendar year.

Applies to:
Pulmozyme
Number of uses:
Per prescription per calendar year

Form more information phone: 877-794-8723 or Visit website

Pulmozyme Co-Pay Card Reimbursement Request

Eligible commercially insured patients may submit a reimbursement request form after paying the provider directly for treatment.

Applies to:
Pulmozyme
Number of uses:
One rebate per prescription fill

Form more information phone: 877-794-8723 or Visit website

Patient Assistance & Copay Programs for Pulmozyme

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Pulmozyme (dornase alfa) Solution; Inhalation

More information please phone: 800-675-8416 Visit Website

Provider: Genentech Patient Foundation

Eligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Based on FPL
  3. Medically appropriate condition/diagnosis
  4. Must be treated by US licensed healthcare provider
  5. The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Pulmozyme (dornase alfa) Solution; Inhalation

More information please phone: 888-941-3331   or 866-422-2377   Visit Website

Provider: Genentech Access Solutions: Pulmozyme

Eligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. Varies
  4. Must be treated by US licensed healthcare provider
  5. Eligibility determined on a case-by-case basis. Contact program for details.
Applicable drugs:
  • Pulmozyme (dornase alfa) Solution; Inhalation

More information please phone: 800-690-3023   or 866-422-2377   Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.